CN103191387A - Medicament for treating juvenile myopia - Google Patents
Medicament for treating juvenile myopia Download PDFInfo
- Publication number
- CN103191387A CN103191387A CN2013101111882A CN201310111188A CN103191387A CN 103191387 A CN103191387 A CN 103191387A CN 2013101111882 A CN2013101111882 A CN 2013101111882A CN 201310111188 A CN201310111188 A CN 201310111188A CN 103191387 A CN103191387 A CN 103191387A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- medicament
- folium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating juvenile myopia. The medicament is prepared from the following materials in parts by weight: 5 to 10 parts of figwort, 10 to 20 parts of dried ginger, 20 to 30 parts of dogwood, 10 to 20 parts of platycodon grandiflorum, 15 to 25 parts of coptis, 5 to 15 parts of chrysanthemum, 10 to 30 parts of solidago, 1 to 15 parts of henbane, 10 to 20 parts of ephedra, 15 to 30 parts of pyrrosia, 20 to 30 parts of cinnamon, 1 to 20 parts of morinda officinalis, 1 to 20 parts of celandine, 10 to 25 parts of lalang grass rhizome, 10 to 30 parts of cocklebur fruit, 1 to 20 parts of emblic leafflower fruit, 15 to 20 parts of murraya paniculata, 10 to 20 parts of semen pharbitidis, 15 to 20 parts of kapok, 15 to 30 parts of safflower, 10 to 20 parts of polygala, 10 to 25 parts of senna leaf, 5 to 15 parts of aleppo avens, 1 to 20 parts of uniflower swisscentaury root, 15 to 25 parts of dahurian rhododendron leaf, 15 to 25 parts of potentilla discolor, 10 to 20 parts of physalis permviana, 15 to 25 parts of cortex dictamni, 20 to 30 parts of lindley eupatorium herb, 1 to 20 parts of gordon euryale and 10 to 25 parts of Chinese azalea flower. All components of the medicament for treating the juvenile myopia are natural materials, so the medicament is high in safety, definite in treatment effect and suitable to be clinically popularized in a large scale.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of adolescent myopia.
Background technology
Myopia is a kind of commonly encountered diseases, frequently-occurring disease, and it can only be seen and closely can not see far.This eye after the dioptric system refractive power of directional light through having a look at that comes from unlimited distance, assembled focus before retina when rest, then form unclear picture on retina, and distant vision obviously reduces, but near vision is still normal.This disease generally just forms in the teenager stage.In recent years, in China students in middle and primary schools, bathomorphic sickness rate increases year by year.Only according to the statistics in 92 years of State Education Commission, students in middle and primary schools' myopia rate is 74.78% up to 49.47%, ten adolescent myopia rate below eight years old, and is the trend that rises year by year, has a strong impact on student's physical and mental health.
The bathomorphic method for the treatment of is a lot of at present, and for example therapies such as vision correction instrument, Micropole glasses, laser therapy, magnetic therapy, electrotherapy, acupuncture are generally.Although various therapies all have certain curative effect, be eased to a certain extent, most of curative effects are not consolidated.Current still do not have a kind of method preferably to bathomorphic treatment.Glasses for the myopia are worn in being still of generally adopting in the society now.Though wearing glasses for the myopia can correct defects of vision, regulate diopter, but to the no therapeutical effect of eyes itself, and it is more big more to wear its number of degrees, can not stop the development of myopia, the current medical worker who presses for medical technical field is for the Hope Project of motherland keeps punching, solve prevention, treatment, the consolidation of vast adolescent myopia oculopathy as early as possible, problems such as thorough radical cure.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of adolescent myopia.
In order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of adolescent myopia, it is to be made by following materials by weight: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Rhizoma Coptidis 15-25 part, Flos Chrysanthemi 5-15 part, Herba Solidaginis 10-30 part, Semen Hyoscyami 1-15 part, Herba Ephedrae 10-20 part, Folium Pyrrosiae 15-30 part, Cortex Cinnamomi 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Flos Bombacis Malabarici 15-20 part, Flos Carthami 15-30 part, Radix Polygalae 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Dictamni 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Semen Euryales 1-20 part and Flos Rhododendri Mollis 10-25 part.
Preferably, the medicament for the treatment of adolescent myopia of the present invention is to be made by following materials by weight: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of Rhizoma Coptidis, 13 parts of Flos Chrysanthemis, 28 parts of Herba Solidaginiss, 11 parts of Semen Hyoscyamis, 17 parts in Herba Ephedrae, 24 parts of Folium Pyrrosiaes, 27 parts of Cortex Cinnamomis, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Flos Bombacis Malabaricis, 15 parts on Flos Carthami, 14 parts of Radix Polygalaes, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Dictamni, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Semen Euryaless and Flos Rhododendri Mollis.
More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.
Whole compositions of the medicament for the treatment of adolescent myopia of the present invention all are natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.
The specific embodiment
Further specify the present invention below by embodiment.It should be understood that embodiments of the invention are for explanation the present invention rather than limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Except as otherwise noted, otherwise the percent among the present invention is percetage by weight.
Embodiment decoction of the present invention
Take by weighing Radix Scrophulariae 7 grams, Rhizoma Zingiberis 13 grams, Fructus Corni 22 grams, Radix Platycodonis 15 grams, Rhizoma Coptidis 21 grams, Flos Chrysanthemi 13 grams, Herba Solidaginis 28 grams, Semen Hyoscyami 11 grams, Herba Ephedrae 17 grams, Folium Pyrrosiae 24 grams, Cortex Cinnamomi 27 grams, Radix Morindae Officinalis 18 grams, Herba Chelidonii 17 grams, Rhizoma Imperatae 23 grams, Fructus Xanthii 21 grams, Fructus Phyllanthi 16 grams, Folium Et Cacumen Murrayae 16 grams, Semen Pharbitidis 17 grams, Flos Bombacis Malabarici 19 grams, Flos Carthami 15 grams, Radix Polygalae 14 grams, Folium Sennae 21 grams, Radix seu Herba Gei aleppici 11 grams, Radix Rhapontici 13 grams, Folium Rhododendri Daurici 23 grams, Herba Potentillae Discoloris 24 grams, Calyx Seu Fructus Physalis 14 grams, Cortex Dictamni 25 grams, Herba Eupatorii Lindleyani 26 grams, Semen Euryales 16 grams and Flos Rhododendri Mollis 24 grams, add water 2000 milliliters, in the flask of condensing tube is housed, heated 4 hours down at 80 ℃, filter.Filtrate is concentrated into 600 milliliters, namely gets decoction of the present invention.
Experimental example
Physical data:
Adolescent myopia 50 examples, male's 25 examples wherein, women's 25 examples.Patient's naked vision is lower than 4.8 (standard logarithmic visual acuity chart lamp SLD-II-types); Get rid of organic disease through slit lamp, ophthalmofundoscopy, be diagnosed as myopia.And the definition of true, the pseudomyopia that meets that Society of Ophthalmology of Chinese Medical Association dioptrics of eye group in 1985 works out and criteria for classification (referring to " modern ophthalmology handbook, Beijing, People's Health Publisher,, 563-564 page or leaf in 1993).At random it is divided into treatment group and matched group.25 examples are organized in treatment, age 8-18 year, average 13.5 years old, course of disease February-6 year; Matched group 25 examples, age 8-18 year, average 14 years old, course of disease February-6 year.Two groups of cases are learned the processing there was no significant difference by statistics at aspects such as age, the course of disease and clinical manifestation, myopic degrees.
Therapeutic scheme
Treatment group: use the decoction for preparing among the embodiment.Take each 20 milliliters every day 2 times.One month is 1 course for the treatment of.
Matched group: use Tropicamide collyrium (available from Guangzhou strong psychological treatment industry company limited), drip 4 before sleeping every night, one month is 1 course for the treatment of.
Criterion of therapeutical effect
Produce effects: vision improves 〉=2 row; Effectively: vision improves 〉=1 row＜2 row; Invalid: vision does not have obvious raising less than 1 row or the descender is arranged.
Treat the result after a course for the treatment of:
Treatment group: produce effects 15 examples, effective 10 examples, total effective rate 100%.
Matched group: produce effects 0 example, effective 15 examples, invalid 10 examples, total effective rate 60%.
Claims (3)
1. medicament for the treatment of adolescent myopia, it is characterized in that it is to be made by following materials by weight: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Rhizoma Coptidis 15-25 part, Flos Chrysanthemi 5-15 part, Herba Solidaginis 10-30 part, Semen Hyoscyami 1-15 part, Herba Ephedrae 10-20 part, Folium Pyrrosiae 15-30 part, Cortex Cinnamomi 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Flos Bombacis Malabarici 15-20 part, Flos Carthami 15-30 part, Radix Polygalae 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Dictamni 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Semen Euryales 1-20 part and Flos Rhododendri Mollis 10-25 part.
2. the medicament for the treatment of adolescent myopia according to claim 1, it is characterized in that it is to be made by following materials by weight: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of Rhizoma Coptidis, 13 parts of Flos Chrysanthemis, 28 parts of Herba Solidaginiss, 11 parts of Semen Hyoscyamis, 17 parts in Herba Ephedrae, 24 parts of Folium Pyrrosiaes, 27 parts of Cortex Cinnamomis, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Flos Bombacis Malabaricis, 15 parts on Flos Carthami, 14 parts of Radix Polygalaes, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Dictamni, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Semen Euryaless and Flos Rhododendri Mollis.
3. the medicament for the treatment of adolescent myopia according to claim 1 is characterized in that, described medicament can be tablet, dispersible tablet, capsule or decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310111188.2A CN103191387B (en) | 2013-03-22 | 2013-03-22 | Medicament for treating juvenile myopia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310111188.2A CN103191387B (en) | 2013-03-22 | 2013-03-22 | Medicament for treating juvenile myopia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103191387A true CN103191387A (en) | 2013-07-10 |
| CN103191387B CN103191387B (en) | 2014-04-30 |
Family
ID=48714320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310111188.2A Expired - Fee Related CN103191387B (en) | 2013-03-22 | 2013-03-22 | Medicament for treating juvenile myopia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103191387B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1111148A (en) * | 1995-02-25 | 1995-11-08 | 王存民 | Acupoint application for myopia |
| CN101129610A (en) * | 2007-08-21 | 2008-02-27 | 王军 | Vitality raising pill of glutinous rehmannia |
| CN102488269A (en) * | 2011-04-21 | 2012-06-13 | 深圳市唤然生物科技开发有限公司 | Blueberry health-care beverage and its preparation method |
-
2013
- 2013-03-22 CN CN201310111188.2A patent/CN103191387B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1111148A (en) * | 1995-02-25 | 1995-11-08 | 王存民 | Acupoint application for myopia |
| CN101129610A (en) * | 2007-08-21 | 2008-02-27 | 王军 | Vitality raising pill of glutinous rehmannia |
| CN102488269A (en) * | 2011-04-21 | 2012-06-13 | 深圳市唤然生物科技开发有限公司 | Blueberry health-care beverage and its preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103191387B (en) | 2014-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105434405A (en) | Eye-protection mask, and preparation method thereof | |
| CN103768283A (en) | Traditional Chinese medicine for treating multiple eye diseases | |
| CN101954028A (en) | Medicinal pillow for preventing and treating myopic eyes | |
| CN100364593C (en) | Oral liquid for promoting eyesight and protecting eye | |
| CN104971304A (en) | Xerophthalmia treatment medicine | |
| CN102670993B (en) | Traditional Chinese medicine for treating cataract | |
| CN101797314B (en) | Medicinal composition for treating adolescent myopia and preparation method thereof | |
| CN101647913B (en) | Traditional Chinese medicine preparation for treating senile cataract and viral keratitis | |
| CN102579991A (en) | Chinese medicinal inflammation diminishing preparation for treating herpes simplex keratitis | |
| CN105983026A (en) | Moxibustion therapy preparation for treating myopia | |
| CN103191387B (en) | Medicament for treating juvenile myopia | |
| CN107929356B (en) | Eye drop and preparation method and application thereof | |
| CN102670851B (en) | Selenium-enriched traditional Chinese medicinal herb eye refreshing drops | |
| CN112451622A (en) | A preparation for treating myopia, amblyopia and astigmatism, and its preparation method | |
| CN101293056B (en) | Medicament for preventing and treating near-sightedness | |
| CN110339314A (en) | A kind of eyesight patch and preparation method thereof | |
| CN104644747A (en) | Eye compress liquid mainly for treating pseudomyopia | |
| CN103751358B (en) | A kind of Chinese medicine composition for rescuing ametropia ophthalmic | |
| CN102579724B (en) | Chinese medicine composition for treating glaucoma | |
| CN102755549A (en) | Drug for curing cataract and preparation method thereof | |
| CN1073600A (en) | The preparation method of the Chinese medicine preparation of treatment pseudomyopia | |
| CN101693075B (en) | Traditional Chinese medicine for treating senile cataract | |
| CN107412539A (en) | Prevent and treat the herbal application of myopia | |
| CN108404052A (en) | Prevention myopia, the pharmaceutical composition and the preparation method and application thereof of amblyopia | |
| CN103961491A (en) | Traditional Chinese medicine for treating amblyopia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: LI JUN Free format text: FORMER OWNER: SHI QIUHUA Effective date: 20140327 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Li Jun Inventor after: Jiang Suxia Inventor before: Shi Qiuhua |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: SHI QIUHUA TO: LI JUN JIANG SUXIA Free format text: CORRECT: ADDRESS; FROM: 272300 JINING, SHANDONG PROVINCE TO: 272000 JINING, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20140327 Address after: Supply road 272000 in Shandong province Jining City No. 12 Jining Maternal and Child Health-Care Hospital Applicant after: Li Jun Address before: 1 road 272300 Shandong province Yutai County Hu Ling Applicant before: Shi Qiuhua |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140430 Termination date: 20150322 |
|
| EXPY | Termination of patent right or utility model |